Catalyst Biosciences Stock Operating Margin
| CBIODelisted Stock | USD 0.41 0.02 4.65% |
Catalyst Biosciences fundamentals help investors to digest information that contributes to Catalyst Biosciences' financial success or failures. It also enables traders to predict the movement of Catalyst Stock. The fundamental analysis module provides a way to measure Catalyst Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Catalyst Biosciences stock.
Catalyst |
Catalyst Biosciences Company Operating Margin Analysis
Catalyst Biosciences' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Catalyst Biosciences has an Operating Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The operating margin for all United States stocks is 100.0% lower than that of the firm.
Catalyst Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Catalyst Biosciences' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Catalyst Biosciences could also be used in its relative valuation, which is a method of valuing Catalyst Biosciences by comparing valuation metrics of similar companies.Catalyst Biosciences is currently under evaluation in operating margin category among its peers.
Catalyst Fundamentals
| Return On Equity | -2.69 | |||
| Return On Asset | -0.38 | |||
| Current Valuation | 51.03 M | |||
| Shares Outstanding | 37.97 M | |||
| Shares Owned By Insiders | 27.73 % | |||
| Shares Owned By Institutions | 8.75 % | |||
| Number Of Shares Shorted | 34.05 K | |||
| Price To Earning | (0.34) X | |||
| Price To Book | 0.53 X | |||
| Price To Sales | 4.82 X | |||
| Revenue | 794 K | |||
| Gross Profit | (64.91 M) | |||
| EBITDA | (52.15 M) | |||
| Net Income | (8.24 M) | |||
| Cash And Equivalents | 75.39 M | |||
| Cash Per Share | 2.39 X | |||
| Total Debt | 38 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 18.86 X | |||
| Book Value Per Share | (0.78) X | |||
| Cash Flow From Operations | (33.1 M) | |||
| Short Ratio | 0.19 X | |||
| Earnings Per Share | (1.50) X | |||
| Price To Earnings To Growth | 0.02 X | |||
| Target Price | 16.0 | |||
| Beta | 1.29 | |||
| Market Capitalization | 19.37 M | |||
| Total Asset | 28.44 M | |||
| Retained Earnings | (410.94 M) | |||
| Working Capital | 11.38 M | |||
| Current Asset | 68.7 M | |||
| Current Liabilities | 37.76 M | |||
| Annual Yield | 7.93 % | |||
| Net Asset | 28.44 M |
About Catalyst Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Catalyst Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Catalyst Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Catalyst Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Catalyst Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Catalyst Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Catalyst Stock
| 0.92 | KO | Coca Cola Sell-off Trend | PairCorr |
| 0.89 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.88 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.87 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.86 | TLK | Telkom Indonesia Tbk | PairCorr |
The ability to find closely correlated positions to Catalyst Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Catalyst Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Catalyst Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Catalyst Biosciences to buy it.
The correlation of Catalyst Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Catalyst Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Catalyst Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Catalyst Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Catalyst Stock
If you are still planning to invest in Catalyst Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalyst Biosciences' history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |